Histamine <scp>H3</scp> and <scp>H4</scp> Receptor Antagonists Differentially Inhibit Mast Cell Activation via <scp>FcεRI</scp> and <scp>MRGPRX2</scp> Pathways
Authors
- Jiahua Guo (ORCID: https://orcid.org/0000-0002-8215-3726)
- Dan Ye (ORCID: https://orcid.org/0000-0001-5419-0522)
- Songmei Geng (ORCID: https://orcid.org/0000-0001-8731-6267)
- Xi Zhao (ORCID: https://orcid.org/0000-0001-7002-8613)
- Weihui Zeng (ORCID: https://orcid.org/0009-0002-7663-6112)
- Zhao Wang (ORCID: https://orcid.org/0000-0002-2679-5695)
- Hongmei Zhou (ORCID: https://orcid.org/0000-0002-5282-3004)
- Mengyao Yang (ORCID: https://orcid.org/0000-0003-4218-7670)
- Yuxin Zhang (ORCID: https://orcid.org/0000-0003-0794-7646)
Institutions
- Second Affiliated Hospital of Xi'an Jiaotong University (CN)
Publication Details
- Journal
- Clinical & Experimental Allergy
- Published
- 2025-04-02
- DOI
- https://doi.org/10.1111/cea.70048
- Primary Topic
- Mast cells and histamine
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Natural Science Basic Research Program of Shaanxi Province